iFAST Diagnostics raised €5.8M in a funding round in May 2026. The company is based in London, UK. Investors in the round: Qantx, existing subscribers, Innovate UK grant and 4 others. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
